BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 31706945)

  • 1. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D; Nandan SRK; Kulkarni PG
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Salivary MicroRNA and Cytokines in the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
    Manzano-Moreno FJ; Costela-Ruiz VJ; García-Recio E; Olmedo-Gaya MV; Ruiz C; Reyes-Botella C
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
    Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
    Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
    Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
    Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.
    Heawchaiyaphum C; Pientong C; Phusingha P; Vatanasapt P; Promthet S; Daduang J; Teeramatwanich W; Kongyingyoes B; Chuerduangphui J; Ekalaksananan T
    J Proteomics; 2018 Feb; 173():52-61. PubMed ID: 29199150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential salivary biomarker panels for oral squamous cell carcinoma.
    Jain A; Kotimoole CN; Ghoshal S; Bakshi J; Chatterjee A; Prasad TSK; Pal A
    Sci Rep; 2021 Feb; 11(1):3365. PubMed ID: 33564003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary metabolite signatures of oral cancer and leukoplakia.
    Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
    Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.
    Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary proteomics for oral cancer biomarker discovery.
    Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
    Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
    Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
    J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
    Ploypetch S; Roytrakul S; Jaresitthikunchai J; Phaonakrop N; Krobthong S; Suriyaphol G
    PLoS One; 2019; 14(7):e0219390. PubMed ID: 31318878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
    Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
    J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Cargo of Salivary Small Extracellular Vesicles as Potential Functional Signature of Oral Squamous Cell Carcinoma.
    Fontana S; Mauceri R; Novara ME; Alessandro R; Campisi G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population.
    Brinkmann O; Kastratovic DA; Dimitrijevic MV; Konstantinovic VS; Jelovac DB; Antic J; Nesic VS; Markovic SZ; Martinovic ZR; Akin D; Spielmann N; Zhou H; Wong DT
    Oral Oncol; 2011 Jan; 47(1):51-5. PubMed ID: 21109482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
    Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
    Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls.
    Seyedmajidi S; Seyedmajidi M; Foroughi R; Zahedpasha A; Zolfaghari Saravi Z; Pourbagher R; Bijani A; Motallebnejad M; Monfared Shabestani A; Mostafazadeh A
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3059-3063. PubMed ID: 30485941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients.
    Gissi DB; Gabusi A; Tarsitano A; Asioli S; Rossi R; Marchetti C; Montebugnoli L; Foschini MP; Morandi L
    Cancer Biomark; 2020; 28(4):499-510. PubMed ID: 32568174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.